TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 176 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.28 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $106 | -87.9% | 11,862 | -79.2% | 0.00% | -100.0% |
| Q2 2023 | $873 | -61.7% | 56,900 | -43.9% | 0.00% | -66.7% |
| Q1 2023 | $2,280 | -13.7% | 101,415 | -19.2% | 0.00% | -25.0% |
| Q4 2022 | $2,641 | -84.5% | 125,589 | +17764.7% | 0.00% | – |
| Q2 2022 | $17,000 | -10.5% | 703 | -6.8% | 0.00% | – |
| Q1 2022 | $19,000 | -87.8% | 754 | -85.1% | 0.00% | – |
| Q4 2021 | $156,000 | +44.4% | 5,053 | +12.9% | 0.00% | – |
| Q3 2021 | $108,000 | +10.2% | 4,475 | +23.8% | 0.00% | – |
| Q4 2020 | $98,000 | – | 3,616 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lynx1 Capital Management LP | 411,680 | $10,609,000 | 9.85% |
| VR Adviser, LLC | 1,994,997 | $51,411,000 | 8.33% |
| Kynam Capital Management, LP | 870,918 | $22,444,000 | 7.28% |
| GREAT POINT PARTNERS LLC | 1,010,000 | $26,028,000 | 6.29% |
| Deep Track Capital, LP | 3,134,503 | $80,776,000 | 5.18% |
| RA Capital Management | 4,922,941 | $126,864,000 | 2.77% |
| ARMISTICE CAPITAL, LLC | 4,958,000 | $127,768,000 | 2.47% |
| MPM BioImpact LLC | 277,950 | $7,163,000 | 1.92% |
| Sofinnova Investments, Inc. | 658,249 | $16,963,000 | 1.29% |
| Perceptive Advisors | 1,845,555 | $47,560,000 | 0.95% |